Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML

Allogeneic hematopoietic stem-cell transplantation (HSCT) remains the only curative option for patients with advanced chronic myeloid leukemia (CML). However, outcome is dismal and of short follow-up. The objective of the study was to determine long-term outcome and risk factors in patients with a h...

Descripción completa

Detalles Bibliográficos
Autores principales: Niederwieser, Christian, Morozova, Elena, Zubarovskaya, Ludmila, Zabelina, Tatjana, Klyuchnikov, Evgeny, Janson, Dietlinde, Wolschke, Christine, Christopeit, Maximilian, Ayuk, Francis, Moiseev, Ivan, Afanasyev, Boris V., Kröger, Nicolaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563424/
https://www.ncbi.nlm.nih.gov/pubmed/34331022
http://dx.doi.org/10.1038/s41409-021-01410-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563424/
https://www.ncbi.nlm.nih.gov/pubmed/34331022
http://dx.doi.org/10.1038/s41409-021-01410-x

Ejemplares similares